Lorne Taichman is Director, Science & Technology at Windham Capital Partners.  Lorne has an MD degree from the University of Toronto and a PhD in Molecular Biology from the University of Wisconsin. Lorne is a professor emeritus at Stony Brook University where he directed a medical research laboratory for 30 years. His field of study was stem cells and gene and cell therapy. He has authored over 60 peer-reviewed publications and, in addition, was the recipient of an NIH MERIT award. In 2000, Lorne spent a sabbatical year at Johnson & Johnson’s Corporate Office of Science and Technology where he evaluated emerging technologies. Lorne remained a part-time consultant to COSAT and in 2007 he left the University to join Windham. As Windham’s Director of Science & Technology, Lorne assists in locating new technologies for our review and in critically assessing the opportunity they present.